NASDAQ · FRSX

Foresight Autonomous Holdings Ltd.. American

$1.35 -$0.05 (-3.43%) 1D After hours

Key Metrics

$4.03M
Market cap
P/E · TTM
$398.00K
Revenue · TTM
−$12.10M
Net income
EPS · TTM $-0.26
Dividend yield
Free cash flow −$10.48M
Beta · 1Y 1.97
EBITDA · TTM −$12.02M
Gross margin 64.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Jan 29 high, the share price fell 57%.

    Peak close $3.15 on Jan 29; trough close $1.35 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -57%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 8
    The stock moved -25.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 8
  • Mar 13
    The stock moved -25.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.03M
Enterprise value
Shares outstanding3.0M
52-wk range$1.22 – $4.47
Avg volume · 20D107.9K
Net cash
Book value / share$0.13
ExchangeNASDAQ
About Foresight Autonomous Holdings Ltd.. American
IPO dateJun 15, 2017
Employees74

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S10.12
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 64.8%
Operating -3,060.6%
Net -3,041.0%
FCF -2,632.7%
ROE / ROIC -196.8% · —

Financial Health

Current ratio3.30
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.76M

Cash Flow · TTM

Operating CF −$10.45M
Capex −$25.00K
Free cash flow −$10.48M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-27.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings